Curated News
By: NewsRamp Editorial Staff
November 16, 2026
NOVA Medical Launches Surgeon-Guided Wound Care Platform
TLDR
- NOVA Medical offers manufacturers a shared-success commercialization path with portfolio equity, reducing the need to build national sales infrastructure independently.
- NOVA Medical uses a five-stage tissue repair portfolio and a surgeon innovation network to identify clinical needs before selecting technologies.
- NOVA Medical prioritizes patient-centered wound care and integrity while launching Women in Wound Care to advance professional education and mentorship.
- NOVA Medical combines 150 years of plastic surgery expertise with 75 years of commercialization leadership and plans a 2027 commercial launch.
Impact - Why it Matters
This news matters because it signals a shift in how medical technologies are commercialized in wound care—moving from product-first strategies to a clinical-need-first approach that prioritizes patient outcomes. By uniting surgeons, manufacturers, and commercial experts in a collaborative model, NOVA Medical could accelerate access to innovative tissue repair technologies, reduce inefficiencies, and align incentives across the healthcare ecosystem. For clinicians, this means more thoughtfully curated tools that support decision-making; for manufacturers, a streamlined path to market; and for patients, potentially better care. The formation of Women in Wound Care also addresses the need for diversity and mentorship in the field, which can drive long-term improvements in wound care delivery.
Summary
NOVA Medical, LLC, an emerging tissue repair and regenerative medicine company based in San Antonio, Texas, has officially announced its formation with a mission to transform how innovative medical technologies reach the U.S. healthcare market. Founded by experienced wound care leaders Dr. Christine Grogan (CEO), Chris Bauer (Chief Commercial Officer), and Dawn Shepard (Chief Clinical Officer), NOVA is building a commercialization platform grounded in transparency, integrity, and patient-centered decision-making. The company is guided by plastic surgeons and tissue repair surgeons through its Plastic Surgeon Tissue Repair Surgeon Innovation Network, which helps identify unmet clinical needs, evaluate emerging technologies, and inform portfolio selection. NOVA’s portfolio strategy spans five interconnected stages of tissue repair: Prevent, Assess, Prepare, Restore, and Close. For clinicians, NOVA aims to provide access to thoughtfully selected, complementary technologies that support clinical decision-making throughout the tissue repair journey. For manufacturers, NOVA offers an alternative path to commercialization—combining clinical insight, experienced commercial leadership, and shared market access without requiring each company to build a national sales infrastructure independently. The collaborative business model aligns the interests of manufacturers, surgeons, and the commercial organization, with participating manufacturers potentially sharing in the portfolio’s broader financial success.
NOVA’s leadership brings decades of experience in advanced wound care, medical devices, biologics, clinical practice, and commercialization, including leadership roles at KCI and other established medical technology organizations. The company’s operating model combines NOVA Distribution, its primary commercial engine, with NOVA Consulting, which supports manufacturers preparing to enter the U.S. market. NOVA also intends to evaluate opportunities to develop or acquire technologies that complement its portfolio. Its broader vision is complemented by Women in Wound Care, an independently governed nonprofit focused on professional education and leadership development. NOVA is advancing surgeon collaboration, manufacturer engagement, and organizational development in preparation for an anticipated 2027 commercial launch. For more information, visit novamedical1.com or womeninwoundcare.org.
Source Statement
This curated news summary relied on content distributed by 24-7 Press Release. Read the original source here, NOVA Medical Launches Surgeon-Guided Wound Care Platform
